Penumbra Inc (NYSE:PEN)
$ 209.63 0.89 (0.43%) Market Cap: 8.14 Bil Enterprise Value: 8.00 Bil PE Ratio: 616.56 PB Ratio: 7.01 GF Score: 86/100

Penumbra Inc at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 12:00PM GMT
Release Date Price: $279.06 (+6.47%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to kick off our 2023 health care conference with Penumbra. With us this morning, we have Adam Elsesser, Chairman, President and CEO; Jason Mills, Executive Vice President of Strategy; and Jee Hamlyn-Harris, Head of Investor Relations.

In terms of format, it's going to be a fireside chat. If anybody has a question they want to ask, just raise your hand, and we'll come around with the mic. So Adam, thanks so much for being here.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Thank you for having us.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

So Adam, I wanted to start off -- I always like to start off with a big picture question. And you gave a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot